• No results found

[PDF] Top 20 Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?

Has 10000 "Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?" found on our website. Below are the top 20 most common "Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?".

Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?

Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?

... cells could produce factors that induce the formation of tight junctions con- ferring barrier properties to the retinal vessels ...of diabetic retinopathy: vascular leakage and capillary ... See full document

9

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications

... Abstract: Alpha 1 antitrypsin deficiency is a hereditary condition characterized by low alpha 1 proteinase inhibitor (also known as alpha 1 antitrypsin [AAT]) serum ... See full document

14

<p>Targeting Netrin-1 and -4 as a Novel Diagnostic Parameter and Treatment Option for Diabetic Retinopathy</p>

<p>Targeting Netrin-1 and -4 as a Novel Diagnostic Parameter and Treatment Option for Diabetic Retinopathy</p>

... Different conventional and newer diagnostic tools including glycated hemoglobin (HbA1c), thioredoxin- interacting protein, fructosamine, and glycated albumin have been used for detection of retinopathy in ... See full document

7

Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy

Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy

... it could improve the median motor nerve conduction velocity (MNCV) and sensory nerve conduction velocity (SNCV), peroneal MNCV, and SNCV after 14, 21, and 28 days of treatment and could reduce the Toronto ... See full document

14

Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy

Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy

... An earlier study by Cunha-Vaz et al. [20] observed that the degree of decrease in retinal fluid in the outer layers of retina is a more robust biomarker of BCVA recovery than central retinal thickness, disorganization of ... See full document

5

Z type alpha 1 antitrypsin is less competent than M1 type alpha 1 antitrypsin as an inhibitor of neutrophil elastase

Z type alpha 1 antitrypsin is less competent than M1 type alpha 1 antitrypsin as an inhibitor of neutrophil elastase

... of alpha 1AT of only 80 mg/dl protect the lung from an increased risk of ...of alpha 1AT by virtue of an inability of the Z-type alpha 1AT molecule to inhibit neutrophil elastase as effectively as ... See full document

10

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

... Diabetes Retinopathy Study (ETDRS) has staged NPDR with mild, moderate, and severe grades, aimed to screen risk factors and to detect the earlier stages of DR for nonsurgical treatment, eg, retinal ... See full document

9

Alpha 1 antitrypsin is a potential biomarker for hepatitis B

Alpha 1 antitrypsin is a potential biomarker for hepatitis B

... In order to identify the target proteins in the progress of HBV patients from mild to severe, one-milliliter of serum was collected from each patient of these two groups. The serum from mild and severe group were ... See full document

7

GENETIC HETEROGENEITY OF RABBIT ALPHA-1-ANTITRYPSIN

GENETIC HETEROGENEITY OF RABBIT ALPHA-1-ANTITRYPSIN

... We found interindividual differences in the electrophoretic A-1-AT patterns as well as quantitative differences in the concentrations of A-1-AT and the serum trypsin-inhibit[r] ... See full document

9

Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients?

Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients?

... Angiotensin II activates NADPH oxidase via AT 1 receptor activation in vascular cells. However, NADPH oxidase is probably not the only source of ROS stimulated by angio- tensin II. As we have reviewed, one ... See full document

8

Pulmonary abnormalities in intermediate alpha 1 antitrypsin deficiency

Pulmonary abnormalities in intermediate alpha 1 antitrypsin deficiency

... 'Abbreviations used in this paper: AAT, alpha-l-antitrypsin; COPD, chronic obstructive pulmonary disease; Pi, protease inhibitor; R3, R9, RR, total pulmonary resistance by oscillometric [r] ... See full document

10

Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics

Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics

... Notes: Genetic factors are proposed to play a central role in the pharmacological variation in response. evidences from linkage analysis and human leucocyte antigen (HLA) studies, genome-wide association analysis, and ... See full document

11

Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation

Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation

... (Hp), alpha-1-antitrypsin, apolipoprotein A-IV, serum paraoxonase and Zn-alpha-glycoprotein were increased and the proteins, clusterin precursor, alpha-2-macroglobulin, serum amyloid ... See full document

12

Antielastases of the human alveolar structures  Implications for the protease antiprotease theory of emphysema

Antielastases of the human alveolar structures Implications for the protease antiprotease theory of emphysema

... with alpha 1-antitrypsin deficiency, who have decreased levels of serum alpha 1-antitrypsin and who have progressive panacinar ...homozygous alpha ... See full document

11

Epidemiological Features of Diabetic Retinopathy in Abidjan (Côte d’Ivoire):  A Study about 448 Patients

Epidemiological Features of Diabetic Retinopathy in Abidjan (Côte d’Ivoire): A Study about 448 Patients

... Edematous diabetic Maculopathy is the leading cause of blindness in people under 60 in industrialized countries [1] [2] ...study, diabetic macular edema was more common in type I diabetics, as ... See full document

10

Alpha-1 Antitrypsin Deficiency Presenting with MPO-ANCA Associated Vasculitis and Aortic Dissection

Alpha-1 Antitrypsin Deficiency Presenting with MPO-ANCA Associated Vasculitis and Aortic Dissection

... CT angiography demonstrated a type B aortic dissection, extending from the left subclavian artery to the right superior femoral artery (Figures 1(a) and 1(c)). Visceral perfusion and renal perfusion were ... See full document

5

COPD in individuals with the PiMZ alpha-1 antitrypsin genotype

COPD in individuals with the PiMZ alpha-1 antitrypsin genotype

... et al. [46] conducted a multicentre family-based study in Europe and North America and included 2707 subjects. COPD probands had a smoking history of ⩾5 pack-years and had at least one sibling who had smoked for ⩾ 5 ... See full document

10

A comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha 1 antitrypsin deficiency and non alpha 1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondroma

A comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha 1 antitrypsin deficiency and non alpha 1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondroma

... In the present study and in previous investigations, trans- mission electron microscopy revealed elementary bodies as well as typical and aberrant reticular bodies, thus indicating active infection alongside persistent ... See full document

8

Some Therapeutic Considerations in Diabetic Retinopathy

Some Therapeutic Considerations in Diabetic Retinopathy

... whether it is comparable to human diab e tic reti- nopathy. In previous e fforts to study diabetic retinopathy in experimental animals, only two forms have been avail[r] ... See full document

7

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency

... In order to explain the combination of the two phenom- ena observed in Mmalton, i.e. calcifications and lack of reactivity to the monoclonal ATZ11 antibody, we have in- ferred that Mmalton, among these three variants, is ... See full document

9

Show all 10000 documents...